Insider Transactions in Q4 2021 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 14
2021
|
John Richard Pinion |
SELL
Open market or private sale
|
Direct |
358
-0.71%
|
$28,998
$81.14 P/Share
|
|
Oct 14
2021
|
Emil D Kakkis President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
853
-0.14%
|
$69,093
$81.0 P/Share
|
|
Oct 14
2021
|
Karah Herdman Parschauer EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
310
-1.08%
|
$25,110
$81.14 P/Share
|
|
Oct 14
2021
|
Thomas Richard Kassberg CBO & EVP |
SELL
Open market or private sale
|
Direct |
286
-0.13%
|
$23,166
$81.14 P/Share
|
|
Oct 14
2021
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
140
-0.99%
|
$11,340
$81.14 P/Share
|
|
Oct 14
2021
|
Dennis Karl Huang |
SELL
Open market or private sale
|
Direct |
358
-0.88%
|
$28,998
$81.14 P/Share
|
|
Oct 14
2021
|
Erik Harris EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
303
-1.2%
|
$24,543
$81.14 P/Share
|
|
Oct 14
2021
|
Camille L Bedrosian EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
359
-0.93%
|
$29,079
$81.14 P/Share
|
|
Oct 14
2021
|
Mardi Dier CFO & Executive Vice President |
SELL
Open market or private sale
|
Direct |
3,261
-7.76%
|
$264,141
$81.16 P/Share
|
|
Oct 12
2021
|
Mardi Dier CFO & Executive Vice President |
SELL
Open market or private sale
|
Direct |
3,477
-7.64%
|
$285,114
$82.79 P/Share
|